Pacific Biosciences of California, Inc.
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.795 USD | +4.36% | -1.37% | -81.60% |
05-09 | Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M | MT |
04-22 | JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.60% | 468M | |
+11.50% | 221B | |
+9.37% | 186B | |
+14.67% | 137B | |
+27.40% | 109B | |
-0.04% | 63.09B | |
+13.99% | 52.68B | |
+4.86% | 50.86B | |
+7.70% | 42.53B | |
+7.42% | 37.76B |
- Stock Market
- Equities
- PACB Stock
- News Pacific Biosciences of California, Inc.
- Pacific Biosciences Posts Higher Preliminary Q4, Full-Year 2023 Revenue